Searched for
NOVARTIS PHARMACEUTICALS CORPORATION
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- Déjà Vu? 10 nuclear scientists gone missing or dead in US under mysterious circumstances, nearly a decade after similar incidents in IndiaMysterious disappearances and deaths of at least 10 US scientists since 2023, many linked to national security labs, have sparked alarm. Re...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...
- Alembic Pharmaceuticals gets USFDA nod for generic Carbamazepine tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets (100 mg, 200 mg, ...
- Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazep...
- PE firms queue up for Novartis' Indian armThe PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expec...
- Cipla gets USFDA nod for generic productAccording to IQVIA (IMS Health), Durezol had US sales of around USD 106 million for the 12-month period ending June 2021.
- Glenmark Pharmaceuticals gets USFDA nod for Fingolimod capsules"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod...
- Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tabletsThe company has received the final approval from the United States Food & Drug Administration (USFDA) for its abbreviated new drug applicat...
- Lupin launches generic drug used for prevention of organ rejection in kidney transplant in USDrug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection ...
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...
- Anti-diabetic drug cartel issue reaches CCI, Health MinistryCCI had been informed about the cartelisation allegations in a letter dated Feb 27, ET reported earlier. At that time, Novartis had denied ...
- Sun Pharma settles Novartis lawsuit over leukemia drugSun Pharmaceutical Industries Ltd said it was allowed to launch a generic version of Novartis' leukemia drug Gleevec in the US
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
- Government refutes Novartis' allegations on patentsYou would appreciate that more than 80 per cent of patents registered in India are attributed to non-Indians," Commerce Secretary S R Rao s...
- Novartis fined $250 mn for discriminationA Novartis pharmaceuticals unit was ordered to pay $250 million in punitive damages to a group of 5,600 female employees after losing a gen...
- Novartis plea on patents struck downThe Madras High Court dismissed a petition by Swiss pharmaceutical giant Novartis challenging the constitutionality of Section 3(d) of the ...
- Trivial change may result in significant inventionsThe debate on patenting of ‘incremental inventions’ has not ended. In fact, it has just begun, with the patent offices in the country flood...
Load More
